CPRX
Price
$22.96
Change
-$0.20 (-0.86%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
2.85B
62 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$4.68
Change
-$0.06 (-1.27%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.26B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CPRX vs SANA

Header iconCPRX vs SANA Comparison
Open Charts CPRX vs SANABanner chart's image
Catalyst Pharmaceuticals
Price$22.96
Change-$0.20 (-0.86%)
Volume$23.31K
Capitalization2.85B
Sana Biotechnology
Price$4.68
Change-$0.06 (-1.27%)
Volume$26.39K
Capitalization1.26B
CPRX vs SANA Comparison Chart in %
CPRX
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CPRX vs. SANA commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Hold and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CPRX: $23.17 vs. SANA: $4.74)
Brand notoriety: CPRX and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 147% vs. SANA: 56%
Market capitalization -- CPRX: $2.82B vs. SANA: $1.24B
CPRX [@Biotechnology] is valued at $2.82B. SANA’s [@Biotechnology] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, CPRX is a better buy in the long-term than SANA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 5 bullish TA indicator(s).

  • CPRX’s TA Score: 4 bullish, 5 bearish.
  • SANA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SANA is a better buy in the short-term than CPRX.

Price Growth

CPRX (@Biotechnology) experienced а +1.98% price change this week, while SANA (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

CPRX is expected to report earnings on Mar 18, 2026.

SANA is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.85B) has a higher market cap than SANA($1.26B). SANA YTD gains are higher at: 16.462 vs. CPRX (-0.728). CPRX has higher annual earnings (EBITDA): 297M vs. SANA (-179.98M). CPRX has more cash in the bank: 690M vs. SANA (153M). CPRX has less debt than SANA: CPRX (2.89M) vs SANA (82.2M). CPRX has higher revenues than SANA: CPRX (578M) vs SANA (0).
CPRXSANACPRX / SANA
Capitalization2.85B1.26B225%
EBITDA297M-179.98M-165%
Gain YTD-0.72816.462-4%
P/E Ratio13.55N/A-
Revenue578M0-
Total Cash690M153M451%
Total Debt2.89M82.2M4%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
35
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPRXSANA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
67%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFYSX14.010.09
+0.65%
Hartford Schroders Intl Multi-Cp Val R4
PURCX20.260.08
+0.40%
PGIM Global Real Estate C
HGXAX17.30-0.02
-0.12%
Hartford Global Impact A
ISFIX18.66-0.14
-0.74%
VY® Columbia Contrarian Core I
VSPGX1012.16-12.60
-1.23%
Vanguard S&P 500 Growth Index Instl

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with VIR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+3.67%
VIR - CPRX
55%
Loosely correlated
+8.08%
IRON - CPRX
46%
Loosely correlated
+2.17%
RGNX - CPRX
43%
Loosely correlated
-0.66%
IDYA - CPRX
41%
Loosely correlated
+5.53%
LGND - CPRX
40%
Loosely correlated
+4.11%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with ABSI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+0.85%
ABSI - SANA
54%
Loosely correlated
+1.21%
VIR - SANA
51%
Loosely correlated
+8.08%
CPRX - SANA
49%
Loosely correlated
+3.67%
CRBU - SANA
48%
Loosely correlated
+1.26%
RXRX - SANA
45%
Loosely correlated
+3.41%
More